Bioorganic and Medicinal Chemistry Letters p. 339 - 344 (1996)
Update date:2022-08-03
Topics:
Xue
Rafalski
Roderick
Eyermann
Mousa
Olson
DeGrado
A potent centrally constrained series of benzimidazole and benzoxazole glycoprotein IIb/IIIa inhibitors has been discovered based on the solution conformation of a cyclic RGD-containing peptide, DMP 728. The high potency of this series of compounds in the inhibition of platelet aggregation requires a benzamidine as the basic moiety and an α-carbamate or sulfonamide substituted β-alanine as the acidic moiety.
View MoreJiaxing Taixin Pharmaceutical Chemical Co., Ltd
Contact:0573-82613601
Address:Chemical Park, Jiaxing, Zhejiang, China
Chengdu Gelipu Biotechnology Co., Ltd.
website:http://www.glp-china.com
Contact:86-28-82610909
Address:chegndu
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
Contact:13357117572
Address:No.149 Shiji dadao Road.
lianyungang jinkang pharmaceutical technology co., ltd.
Contact:008651885445517
Address:Jinshan industrial park, Ganyu county, Lianyungang, Jiangsu Province, 222115, China
Doi:10.1016/0020-1693(95)90040-D
(1995)Doi:10.1023/A:1015054907007
(2002)Doi:10.1021/jo960008k
(1996)Doi:10.1023/A:1012374828303
(2001)Doi:10.1021/ic951550e
(1996)Doi:10.1016/0022-328X(95)05885-S
(1996)